AVEO Oncology
AVEO
#7456
Rank
NZ$0.92 B
Marketcap
NZ$26.63
Share price
0.00%
Change (1 day)
175.21%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$94.7 Million a decrease over its 2020 earnings that were of -NZ$63.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-53.05%
2021 -NZ$94.7 Million49.9%
2020 -NZ$63.17 Million-479.04%
2019 NZ$16.66 M-276.17%
2018 -NZ$9.47 Million-91.79%
2017 -NZ$0.12 Billion142.38%
2016 -NZ$47.56 Million78.51%
2015 -NZ$26.64 Million-71.55%
2014 -NZ$93.63 Million-50.72%
2013 -NZ$0.19 Billion-4.88%
2012 -NZ$0.2 Billion-426.29%
2011 NZ$61.21 M-159.85%
2010 -NZ$0.11 Billion35.33%
2009 -NZ$75.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$59.63 B-115,791.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.26 B-35,524.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$1.79 B-3,582.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$9.17 B-17,889.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.14 B-41,113.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$4.02 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA